Cases & Deals

Funds managed by Invesco Asset Management Limited participate in $27 million Series C financing round of Vedanta Biosciences

Clients Invesco Asset Management Limited

Jones Day advised funds managed by Invesco Asset Management Limited in connection with their participation in the $27 million Series C financing round of Vedanta Biosciences, Inc., a clinical-stage company developing therapies for immune-mediated diseases based on human microbiome-derived bacteria.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.